BMJ  2003;327:809 (4 October), doi:10.1136/bmj.327.7418.809

Letter

"Polypill" to fight cardiovascular disease

Summary of rapid responses

The first 150 words of the full text of this article appear below.

EDITOR—There were some enthusiastic champions of the concept, but, overall, respondents remained to be convinced that the "Polypill" issue was indeed a collector's item and a possible contender for the most important BMJ paper in 50 years, as the editor had indicated.1-5 Images of the tooth fairy and April foolery were invoked, along with gasps of horror, astonishment, and incredulity that the hypothesis should be taken for anything approaching rigorous science.

This was proof, if any were needed, that the BMJ had finally lost the plot, judged several contributors.

Chief among the concerns was the lack of trial evidence for the effectiveness of the Polypill, or any facsimile, for that matter. Wasn't the assumption that the six constituents would work cumulatively and in perfect synergy a foolish one to make on the basis of results from disparate trials? What about the effects of aspirin on people with asthma . . . [Full text of this article]

Caroline White, freelance medical journalist

London E17 4SQ


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Articles

Polypill may be available in two years
Richard Smith
BMJ 2003 327: 0. [Extract] [Full Text] [PDF]

A strategy to reduce cardiovascular disease by more than 80%
N J Wald and M R Law
BMJ 2003 326: 1419. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

  • Choudhry, N. K., Patrick, A. R., Antman, E. M., Avorn, J., Shrank, W. H. (2008). Cost-Effectiveness of Providing Full Drug Coverage to Increase Medication Adherence in Post-Myocardial Infarction Medicare Beneficiaries. Circulation 117: 1261-1268 [Abstract] [Full text]  
  • Stirban, A. O., Tschoepe, D. (2008). Should We Be More Aggressive in the Therapy Against Cardiovascular Risk Factors?: Should we prescribe statin and aspirin for every diabetic patient, or is it time for a polypill?. Diabetes Care 31: S226-S228 [Abstract] [Full text]  
  • Hackam, D. G., Spence, J. D. (2007). Combining Multiple Approaches for the Secondary Prevention of Vascular Events After Stroke: A Quantitative Modeling Study. Stroke 38: 1881-1885 [Abstract] [Full text]  



Access jobs at BMJ Careers
Whats new online at Student 

BMJ